Histogenics was acquired by Ocugen, (Nasdaq: OCGN) on September 27, 2019. Histogenics (Nasdaq: HSGX) is a leader in personalized restorative cell therapies (RCT) for active living. Our first investigational product candidate, NeoCart® is a proprietary RCT that rebuilds a patient’s own knee cartilage, treating pain at the source and potentially preventing progression to osteoarthritis (OA). Read our community guidelines: https://goo.gl/Qtusgh
View Top Employees from Histogenics CorporationWebsite | http://www.histogenics.com |
Ticker | HSGX |
Revenue | $134000 |
Funding | $65 million |
Employees | 13 (13 on RocketReach) |
Founded | 2000 |
Address | 830 Winter St. 3rd Fl, Waltham, Massachusetts 02451, US |
Phone | (781) 547-7900 |
Fax | (781) 547-4452 |
Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Therapeutic Devices, Regenerative Medicine, Healthcare, Science and Engineering, Tissue Engineering, Health Care, Musculoskeletal and Orthopaedics, Drug Manufacturing & Research, Medical, Cartilage Regeneration and Repair |
Web Rank | 2 Million |
Keywords | Histogenics, Histogenics Bylaws, Hsgx, Histogenics Press Releases, Histogenics Corp. E |
Competitors | Alliqua BioMedical, Inc., Cesca Therapeutics Inc., Lisata Therapeutics, Inc., Medtronic Vascular |
SIC | SIC Code 384 Companies, SIC Code 38 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Histogenics Corporation employee's phone or email?
The Histogenics Corporation annual revenue was $134000 in 2024.
13 people are employed at Histogenics Corporation.
Histogenics Corporation is based in Waltham, Massachusetts.
The NAICS codes for Histogenics Corporation are [3254, 32541, 325, 32].
The SIC codes for Histogenics Corporation are [384, 38].